arrow
M

Matthew Zimmerman

hackensack meridian health
H指数:19
被引数:1,499

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lesion penetration predicts tuberculosis treatment shortening through a validated translational tool to de-risk development

病灶穿透通过验证的转化工具预测结核病治疗缩短以降低开发风险

2026-10-140
OAAI
PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes

不同药物治疗方案下卷尾猴结核肺病变的PET/CT成像结果与人类临床结局一致

2026-01-070
PRE
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis
2024-11-060
OAAI
Virus-Shaped Mesoporous Silica Nanostars to Improve the Transport of Drugs across the Blood-Brain Barrier

病毒状介孔二氧化硅纳米星改善药物跨血脑屏障的转运

2024-07-110
OAAI
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential Liabilities
2024-04-062
PRE
Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis- infected rabbits

使肉芽肿血管和基质正常化可改善药物输送并减少结核感染兔的细菌负担

2024-03-262
OAAI
Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
2023-09-1912
OAAI
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria
2023-05-261
OA
A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
2022-09-208
OAAI
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study
2022-03-1517
OA